Log In
Print
BCIQ
Print
Print this Print this
 

DN24-02

Also known as: Lapuleucel-T (APC8024) (formerly Neuvenge)

  Manage Alerts
Collapse Summary General Information
Company Dendreon Corp.
DescriptionAutologous cellular immunotherapy targeting HER2
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu) mRNA
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today